AVN may be an osteoarticular manifestation in primary antiphospholipid syndrome (APS), sometimes as a presenting feature; some of these patients may not have a history of GCs intake, suggesting a role for antiphospholipid antibodies (aPL) in the pathophysiology of AVN [44,45,46,47,52]. The gene discussed is FASLG; the disease is avascular necrosis.